• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不宁腿综合征的药物和非药物治疗

Pharmacologic and Nonpharmacologic Treatment of Restless Legs Syndrome.

作者信息

Anguelova Galia V, Vlak Monique H M, Kurvers Arthur G Y, Rijsman Roselyne M

机构信息

Center for Sleep and Wake Disorders, Haaglanden Medical Center, The Hague, The Netherlands.

Center for Sleep and Wake Disorders, Haaglanden Medical Center, The Hague, The Netherlands.

出版信息

Sleep Med Clin. 2020 Jun;15(2):277-288. doi: 10.1016/j.jsmc.2020.02.013.

DOI:10.1016/j.jsmc.2020.02.013
PMID:32386701
Abstract

This article provides an updated practical guide for the treatment of primary restless legs syndrome (RLS). Articles that appeared after the American Academy of Neurology guideline search were reviewed according to the same evidence rating schedule. We found limited evidence for nonpharmacologic treatment options. In moderate to severe primary RLS, pharmacologic options may be considered, including iron suppletion, an α2δ ligand, a dopamine agonist, a combination of an α2δ ligand and a dopamine agonist, or oxycodone/naloxone. This article includes treatment options in case of augmentation.

摘要

本文提供了一份关于原发性不宁腿综合征(RLS)治疗的最新实用指南。根据相同的证据评级表,对美国神经病学学会指南搜索之后出现的文章进行了审查。我们发现非药物治疗选择的证据有限。对于中度至重度原发性RLS,可考虑药物治疗选择,包括补充铁剂、一种α2δ配体、一种多巴胺激动剂、一种α2δ配体和一种多巴胺激动剂的组合,或羟考酮/纳洛酮。本文还包括了出现增敏现象时的治疗选择。

相似文献

1
Pharmacologic and Nonpharmacologic Treatment of Restless Legs Syndrome.不宁腿综合征的药物和非药物治疗
Sleep Med Clin. 2020 Jun;15(2):277-288. doi: 10.1016/j.jsmc.2020.02.013.
2
Pharmacologic and Nonpharmacologic Treatment of Restless Legs Syndrome.不宁腿综合征的药物和非药物治疗
Sleep Med Clin. 2018 Jun;13(2):219-230. doi: 10.1016/j.jsmc.2018.02.005.
3
Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation.不宁腿综合征/Willis-Ekbom病一线治疗、多巴胺能药物增敏的预防和治疗指南:国际不宁腿综合征研究组、欧洲不宁腿综合征参考网络及不宁腿综合征基金会联合特别工作组
Sleep Med. 2016 May;21:1-11. doi: 10.1016/j.sleep.2016.01.017. Epub 2016 Feb 23.
4
Practice guideline summary: Treatment of restless legs syndrome in adults: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.实践指南摘要:成人不安腿综合征的治疗:美国神经病学学会指南制定、传播与实施小组委员会报告
Neurology. 2016 Dec 13;87(24):2585-2593. doi: 10.1212/WNL.0000000000003388. Epub 2016 Nov 16.
5
Restless legs syndrome: nonpharmacologic and pharmacologic treatments.不宁腿综合征:非药物治疗和药物治疗
Geriatrics. 2007 Oct;62(10):13-6.
6
Management of treatment failure in restless legs syndrome (Willis-Ekbom disease).不宁腿综合征(Willis-Ekbom 病)治疗失败的管理。
Sleep Med Rev. 2018 Oct;41:50-60. doi: 10.1016/j.smrv.2018.01.001. Epub 2018 Jan 9.
7
Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension.羟考酮-纳洛酮控释片治疗前期治疗失败后严重不宁腿综合征的疗效:一项双盲、随机、安慰剂对照试验和开放性扩展研究。
Lancet Neurol. 2013 Dec;12(12):1141-50. doi: 10.1016/S1474-4422(13)70239-4. Epub 2013 Oct 18.
8
Advancing synthetic therapies for the treatment of restless legs syndrome.推进治疗不宁腿综合征的合成疗法。
Expert Opin Pharmacother. 2019 Nov;20(16):1971-1980. doi: 10.1080/14656566.2019.1654997. Epub 2019 Aug 19.
9
French consensus: Treatment of newly diagnosed restless legs syndrome.法国共识:新诊断的不安腿综合征的治疗。
Rev Neurol (Paris). 2018 Sep-Oct;174(7-8):515-521. doi: 10.1016/j.neurol.2018.06.002. Epub 2018 Jul 24.
10
Pharmacotherapy for restless legs syndrome.不宁腿综合征的药物治疗
Expert Opin Pharmacother. 2014 Jun;15(8):1127-38. doi: 10.1517/14656566.2014.908850. Epub 2014 Apr 19.

引用本文的文献

1
Effects of Dietary Supplementation in Patients with Restless Legs Syndrome: A Systematic Review.膳食补充剂对不安腿综合征患者的影响:系统评价。
Nutrients. 2024 Jul 18;16(14):2315. doi: 10.3390/nu16142315.
2
Association of multiple sclerosis with chronic fatigue syndrome, restless legs syndrome, and various sleep disorders, along with the recent updates.多发性硬化症与慢性疲劳综合征、不宁腿综合征及各种睡眠障碍的关联,以及近期的更新情况。
Ann Med Surg (Lond). 2023 May 26;85(6):2821-2832. doi: 10.1097/MS9.0000000000000929. eCollection 2023 Jun.
3
Restless Legs Syndrome in Chronic Kidney Disease- a Systematic Review.
慢性肾脏病中的不宁腿综合征:系统评价。
Tremor Other Hyperkinet Mov (N Y). 2023 Mar 29;13:10. doi: 10.5334/tohm.752. eCollection 2023.
4
Therapeutic effects of magnesium and vitamin B6 in alleviating the symptoms of restless legs syndrome: a randomized controlled clinical trial.镁和维生素 B6 缓解不安腿综合征症状的疗效:一项随机对照临床试验。
BMC Complement Med Ther. 2022 Dec 31;23(1):1. doi: 10.1186/s12906-022-03814-8.
5
Restless Legs Syndrome: Known Knowns and Known Unknowns.不宁腿综合征:已知与未知
Brain Sci. 2022 Jan 16;12(1):118. doi: 10.3390/brainsci12010118.
6
The Efficacy and Safety of Pharmacological Treatments for Restless Legs Syndrome: Systemic Review and Network Meta-Analysis.不宁腿综合征药物治疗的疗效与安全性:系统评价和网状Meta分析
Front Neurosci. 2021 Oct 26;15:751643. doi: 10.3389/fnins.2021.751643. eCollection 2021.
7
Dopamine agonist responsive burning mouth syndrome: Report of eight cases.多巴胺激动剂反应性灼口综合征:8例报告。
World J Clin Cases. 2021 Aug 16;9(23):6916-6921. doi: 10.12998/wjcc.v9.i23.6916.
8
The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond.抗癫痫药物的药理学和临床疗效:从溴化物盐到依诺巴比妥及其他。
CNS Drugs. 2021 Sep;35(9):935-963. doi: 10.1007/s40263-021-00827-8. Epub 2021 Jun 18.
9
Differential functional connectivity in thalamic and dopaminergic pathways in restless legs syndrome: a meta-analysis.不宁腿综合征中丘脑和多巴胺能通路的差异性功能连接:一项荟萃分析。
Ther Adv Neurol Disord. 2020 Aug 3;13:1756286420941670. doi: 10.1177/1756286420941670. eCollection 2020.